1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 951 F.Supp.2d
  5. 951 F.Supp.2d 695 (2013)
 

IN RE FOSAMAX (ALENDRONATE SODIUM)

Civil Action Nos. 11-5304, 08-08.

951 F.Supp.2d 695 (2013)

In re FOSAMAX (ALENDRONATE SODIUM) PRODUCTS LIABILITY LITIGATION. Bernadette Glynn and Richard Glynn, Plaintiffs, v. Merck Sharp & Dohme Corp, Defendant.

United States District Court, D. New Jersey.

June 27, 2013.

Attorney(s) appearing for the Case

Donald A. Ecklund , James E. Cecchi , Carella Byrne Cecchi Olstein Brody & Agnello, P.C., Roseland, NJ, Christopher A. Seeger , David R. Buchanan , Seeger Weiss LLP, Newark, NJ, Edward Braniff , Weitz & Luxenberg, New York, NY, for Plaintiffs.

David J. Heubeck , Venable LLP, Baltimore, MD, Karen A. Confoy , Fox Rothschild LLP, PC, Lawrenceville, NJ, for Defendant.

OPINION

PISANO, District Judge.

Plaintiffs Bernadette Glynn and Richard Glynn ("Plaintiffs") brought this lawsuit against Defendant Merck, Sharp, & Dohme Corp. ("Defendant"), the manufacturer of Fosamax, which is a drug approved by the United States Food and Drug Administration ("FDA") for the treatment and prevention of osteoporosis. This matter is part of the multi-district litigation ("MDL") concerning Fosamax and involves allegations that Fosamax...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases